Wambolt & Associates’s Albemarle ALB Stock Holding History

Wambolt & Associates’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-905	Closed	-$202K	–	243
2023 Q2	$202K	Buy	+905	New	+$185K	0.07%	240

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wambolt & Associates's ALB Position: Q3 2023 in Review

Wambolt & Associates sold out of Albemarle (ALB) in Q3 2023, closing a stake of 905 shares — an estimated $202K sold.

Wambolt & Associates first reported a position in ALB in Q2 2023 and held it in 1 quarter. The position peaked at $202K in Q2 2023. 1,002 funds tracked by Wall St. Rank hold ALB as of Q3 2023.

Wambolt & Associates reported no remaining Albemarle position as of Q3 2023 after selling out during the quarter.
Wambolt & Associates sold 905 Albemarle shares in Q3 2023, an estimated $202K.
Wambolt & Associates first reported a position in Albemarle in Q2 2023 and held it in 1 quarter.
Wambolt & Associates's Albemarle position peaked at $202K in Q2 2023.
1,002 funds tracked by Wall St. Rank held Albemarle as of Q3 2023.

Based on Wambolt & Associates's 13F filing for Q3 2023, filed 7 Nov 2023.